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noncompliant (NC) balloon, and prescribe DAPT).Wehypothesized
that in selected ST elevation myocardial infarction (STEMI) lesions
it would be possible to do away with predilation (one of the Ps) and
this would be associated with reduced slow ﬂow.
Our protocol in STEMI is to pre-treat these patients with aspirin
chewable (325 mg) half tablet, if the patient is on aspirin, full tablet,
if the patient is not on aspirin plus prasugrel 60 mg or clopidogrel
300 mg or ticagrelor 90 mg 2 tabs in the ER. IV access is obtained.
After heparin 5000 IV is administered, the patients are shifted to
the cath lab. Right radial access is obtained. 6F sheath is placed. In
anterior wall MI, we proceed with the XB guiding catheter directly
(as per Direct study protocol). The patients are given Inj. Bivalur-
idin bolus followed by infusion. Heparin plus GP IIB inhibitors are
used in patients who do not receive bivaluridin. 2 orthogonal views
of the infarct related artery are obtained. The lesion is crossed and
thrombosuction is done. For direct BVS deployment, patient has to
satisfy the following criteria: Age< 55 years, no ﬂuoroscopic cal-
cium, no history of prior angina. All patients received intracoronary
(I/C) nikorandil 2 mg and NTG (100 mcg) as per the hemodynamic
status.TheScaffold lengthwaschosenasnormal tonormalvascular
segment. The diameter of the BVS was upsized by 0.5 mm then the
visual estimation of the vessel size. The BVS was deployed very
gradually up to (maximum) 12 atms pressure. I/C NTG/Nikorandil
was repeated. The scaffolds were post-dilated with noncompliant
balloon, over-sizing upto 0.5 mm-more the scaffold size matching
the vessel size. After completion of the BVS deployment, the RCA
angiogramwasobtained in anteriorwallMI. In inferiorwall,MI prior
angiogram of left coronary artery was done, then RCA was hooked,
and the procedure was completed.
Between Jan 2013 to July 2015, 52 scaffolds were deployed in
various lesions of STEMI. 13 scaffolds were deployed without
pre-dilatations of STEMI lesion. The mean ages of the patients
were 36–85 years. 10 were male, diabetes (3 patients), smoking (3
patients), hyperlipidemia (7 patients), obesity (3 patients) were the
coronary risk factors. The total ischemia time was 180  75.8 min.
The door to balloon time was 35  14.5 min. Pre-procedure TIMI
ﬂow as follows TIMI 0–7 patients TIMI I-1, TIMI II-2, and TIMI III-3
patients. Post-procedure ﬂow was TIMI II-1, patient TIMI III-2
patients. LVEF was 35  12% during acute phase, which improved
to 42  12% at 3 months. All the patients are found to be in NHYA
class I at 10 months of follow-up.
From this pilot project, we conclude that in selected STEMI lesions
it is feasible to deploy BVS without lesion pre-dilatation. This is
associated with good in hospital and intermediate term clinical
outcome. A randomized controlled trial is warranted.
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Background: Non-speciﬁc aortoarteritis (NSAA)/Takayasu arteritis
(TA) is an inﬂammatory arteriopathy common in young Asian
females affecting the aorta and its branches leading to signiﬁcant
ischemic events. Progressive NSAAmay lead to obstructive lesions
of all arch vessels leading to disabling neurologic symptoms. There
is limited experience with endovascular revascularization in this
situation. We report results of stent-supported angioplasty to
stenosis of sole surviving arch vessel performed in our center.
Methods: Angioplasty and stent placement were performed in 8
consecutive patients with TA (age, 11–42 years; mean, 28.3  4.1 y)
with cerebrovascular symptoms caused by severe stenotic lesions
of supraaortic (i.e., carotid, vertebral, and brachiocephalic) arteries
from May 2010 to May 2013.
Result: No immediate procedure-related complication orneurologic
deﬁcitsoccurred.Thesymptoms improvedinall patients.Onfollow-
up (mean, 25 7 months; range, 3–49 months), 6 patients were
asymptomatic and twopatients had recurrence of neurologic symp-
toms. These patients had in-stent restenosis of the carotid artery.
Conclusion: Stent-supported angioplasty of a sole supraaortic
artery is safe and feasible and provides good symptomatic relief
in patients with advanced NSAA.
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Introduction: Percutaneous coronary intervention has become
common in the management strategy of patients with chronic
total occlusion. However, despite improving techniques for open-
ing chronic total occlusions, the beneﬁt of successful recanaliza-
tion of the artery remains unclear.
Objectives: The purpose of this study was to know the procedural
success rates, guidewire strategies, in-hospital and one year out-
come of patients undergoing percutaneous coronary intervention
in chronic total occlusion.
Methods: CTO-PCI were attempted in 101 consecutive patients. 79
cases with successful PCI and 22 cases with unsuccessful PCI were
enrolled in the study from January 2013 to February 2013. Chronic
total occlusion was deﬁned as thrombolysis in myocardial infarc-
tion ﬂow grade 0-1 and duration >3 months. Detailed baseline
clinical, angiographic, procedural, and outcome data were col-
lected and compared success versus failed procedures.
Results: Procedural success was seen in 78% patients (79 of 101).
Patients with unsuccessful PCI compared to successful PCI were
mainly male (81.01% vs. 72.3%; p < 0.02), had a higher incidence of
diabetes mellitus (31.1% vs. 20.9%; p < 0.04) and hypertension
(53.3% vs. 42.3%; p < 0.04). Most patients in successful group had
single vessel disease (63.4% vs. 46.7%; p < 0.001) and less three-
vessel disease (11.8% vs. 22.8%) compared to unsuccessful group.
In-hospital MACE was insigniﬁcantly higher in unsuccessful PCI
(33.1% vs. 0%). Unsuccessful PCI was signiﬁcantly associated with
higher rate of one year MACE (61% vs. 18.1%, p = 0.01), especially
revascularization (33.3% vs. 12.2%, p = 0.02).
Conclusions: Patients with successful recanalization of CTO with
PCI have better symptom relief, better clinical outcome, improved
left ventricular function and better long-term survival compared
with patients in whom the attempt to recanalize CTO has failed.
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In the general hypertensive population, renal artery stenosis (RAS)
is the most common secondary cause of hypertension and is
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responsible for around 2–5% of total hypertensive population.
Among patients with renovascular hypertension (RVH), incidence
of atherosclerotic renal artery stenosis (ARAS) is about 80–90%,
whereasﬁbromusculardysplasia (FMD) is responsible only foraround
10% patients. Intimal ﬁbroplasia occurs in less than 10% of all the
patients with FMD.We report a rare case of 28-year-old ladywho had
newly detected hypertension during 12th week of pregnancy later
leading to intra-uterinedeathof the fetusat28weeksofgestation,and
then she was referred to us for evaluation and management and
found to have intimal ﬁbromuscular dysplasia of renal artery, which
was treated successfully with percutaneous intervention.
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Background: Distal embolization of thrombus during primary PCI
results into reduced myocardial perfusion and poor clinical out-
comes. The objective of our study was to assess the role of manual
thrombus aspiration to improve myocardial perfusion occur dur-
ing primary PCI.
Methods: Single center prospective observation study was under-
taken in a tertiary care hospital. Study was carried out on 104
number of patients presented with STEMI of <12 h duration. Of
which, 52 underwent primary PCI with thrombus aspiration and
remaining were opted for conventional primary PCI. Angiographic
and electrocardiographic signs of myocardial perfusion, as well as
clinical outcomes were assessed. The primary end was corrected
TIMI frame count (cTFC) and secondary end points were ST seg-
ment resolution and mortality at 30 days and 6 months.
Results: A cTFC of<30 occurred in 94.23% of patients in primary PCI
with thrombus aspiration group and in 86.53% falling under con-
ventional primary PCI group (p < 0.001). Also a trend was observed
indicating lower incidence of slow or no reﬂow in patients treated
with primary PCI with thrombus aspiration vis-a-vis conventional
primary PCI (3.84% vs 9.61%, p = 0.01). Complete resolution of ST-
segment elevation (>70% ST resolution) occurred in 59.34% and
46.12% patients, respectively (p < 0.005). Further analysis revealed
thatmortality beneﬁtwasnot conferredat 30 days (1.92%and3.84%,
p = 0.21) and 6months (3.84% and 7.69%, p = 0.13) in both the groups.
Conclusion: Our study showeda trend towards improvedmyocardial
perfusion (cTFC and ST segment resolution) with manual thrombus
aspiration during primary PCI as compared to conventional primary
PCI. However, mortality beneﬁt was not conferred with thrombus
aspiration when compared with conventional primary PCI.
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Background: First generation DES, including SES (Sirolimus eluting
stents), have signiﬁcantly reduced rates of re-stenosis and TLR
compared with BMS. But, at the same time, they have been found
to be associated with increased rates of late and very late stent
thrombosis, as well as MI. Improved stent designs with thinner
struts and more biocompatible polymer coatings and optimized
drug elution proﬁles (EES – everolimus-eluting stents) might favor-
ably inﬂuence DES performance. The aim to the study was to test
whether EES prevents clinical ischemic events better as compared
to SES.
Methods: We enrolled 120 patients with a diagnosis of ACS
(NSTEMI or STEMI) who had SVD (discrete lesion in culprit vessel)
on CAG over a 12-month period. Patients were assigned into EES or
SES group. Primary end points studied were CV Death and ACS;
Stent thrombosis and symptomatic in-stent re-stenosis (h/o
Chronic Stable Angina Post-PTCA +50% Late Lumen Loss on CAG).
Results: Incidence of CV death and ACS was 5% and 8.88% in EES
and SES group respectively ( p < 0.05), while that of Stent throm-
bosis was 3.33% and 6.66% ( p < 0.05). When studied in diabetic
subgroup, incidence of CV Death and ACS was 4% and 11.53%
( p < 0.05). Incidence of symptomatic ISR was 3.33% and 6.66% in
the two groups. In the diabetic subgroup, incidence of sympto-
matic ISR was 4% and 7.7%.
Conclusions: Our results support the hypothesis that the safe and
efﬁcacious platform of EES ismore effective in preventing ischemic
events (including stent thrombosis), and ISR than SES (1st genera-
tion DES). The results were in favor of EES when studied in context
of diabetic subgroup as well.
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Sirolimus-eluting stent (SES) is a ﬁrst-generation drug-eluting
stent (DES) and everolimus-eluting stent (EES) is a second genera-
tion drug-eluting stent. These both DES are widely used and most
extensively studied stents. Use of a DES substantially reduces
restenosis after coronary stent implantation; however, late
adverse events like stent thrombosis (ST) and late in-stent rest-
enosis (ISR) requiring target-lesion revascularization (TLR) occur-
ring beyond 1 year are still a problem. Similar outcomes have been
reported in various recent randomized trials comparing EES and
SES.
In this study, retrospective cohort study was done in the patients
who underwent stent implantation using SES or EES in Dhiraj
Hospital, Vadodara. Comparison between SES and EES was done
in patients who presented for follow-up in our cardiology depart-
ment over one year, i.e. May 2014 to May 2015 after their angio-
plasty. Based on angiographic and clinical outcome in terms of late
ST and ISR requiring TRL, outcome variables were set. The study
was carried out for evaluating non-inferiority of EES as compared
to SES in terms of late ST and ISR requiring TRL.
A total of 136 patients who underwent stent implantation using
SES or EES one to one and half year back agreed to be part of our
study and constituted our cohort. Out of these 136 patients, 60 had
SES implantation and 76 had EES implantation. All of these
patients were subjected to coronary angiography after 1 year to
look for patency of the stent. In-stent restenosis (outcome) was
found in 3 patients in SES group and 4 patients in EES group,
respectively.
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